epigallocatechin gallate has been researched along with Hyperlipemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Gong, Y; Gong, Z; Huang, H; Liu, B; Xiao, W | 1 |
| Adnan, M; Badraoui, R; Ben-Nasr, H; Chappard, D; El-Feki, A; Gargouri, M; Kausar, MA; Magné, C; Saeed, M; Siddiqui, AJ; Snoussi, M; Soussi, A | 1 |
| Chen, CH; Geng, F; Hong, T; Hu, JL; Huang, XJ; Li, MZ; Nie, SP; Wen, JJ; Yang, JR | 1 |
| Lu, Y; Ren, Z; Yang, H; Yang, Z; Zhang, R | 1 |
| Dalal, PS; Joshi, SR; Pandit, AP; Patole, VC | 1 |
| do Nascimento, CO; Lira, F; Mennitti, L; Okuda, M; Oyama, L; Ribeiro, E; Santamarina, A; Santana, A; Seelaender, M; Souza, G; Venancio, D | 1 |
| Chen, IJ; Chiu, JP; Hsu, CH; Liu, CY | 1 |
1 trial(s) available for epigallocatechin gallate and Hyperlipemia
| Article | Year |
|---|---|
Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial.
Topics: Adult; Anti-Obesity Agents; Body Mass Index; Camellia sinensis; Catechin; Dietary Supplements; Double-Blind Method; Female; Food Preservation; Ghrelin; Humans; Hyperlipidemias; Hypolipidemic Agents; Middle Aged; Obesity, Abdominal; Oxidation-Reduction; Patient Dropouts; Plant Extracts; Plant Leaves; Taiwan; Waist Circumference; Weight Loss | 2016 |
6 other study(ies) available for epigallocatechin gallate and Hyperlipemia
| Article | Year |
|---|---|
Metagenomics Approach to the Intestinal Microbiome Structure and Abundance in High-Fat-Diet-Induced Hyperlipidemic Rat Fed with (-)-Epigallocatechin-3-Gallate Nanoparticles.
Topics: Animals; Catechin; Cholesterol; Diet, High-Fat; Gastrointestinal Microbiome; Hyperlipidemias; Metagenomics; Molecular Docking Simulation; Nanoparticles; Rats; Spectroscopy, Fourier Transform Infrared | 2022 |
(-)-Epigallocatechin gallate (EGCG) pharmacokinetics and molecular interactions towards amelioration of hyperglycemia, hyperlipidemia associated hepatorenal oxidative injury in alloxan induced diabetic mice.
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Catechin; Diabetes Mellitus, Experimental; Hyperglycemia; Hyperlipidemias; Liver; Mice; Oxidative Stress | 2022 |
Tea polyphenol and epigallocatechin gallate ameliorate hyperlipidemia via regulating liver metabolism and remodeling gut microbiota.
Topics: Animals; Bacteroidetes; Gastrointestinal Microbiome; Hyperlipidemias; Liver; Metabolic Diseases; Polyphenols; Rats; Tea | 2023 |
Anti‑glycolipid disorder effect of epigallocatechin‑3‑gallate on high‑fat diet and STZ‑induced T2DM in mice.
Topics: Animals; Blood Glucose; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Endothelial Cells; Glycolipids; Hypercholesterolemia; Hyperlipidemias; Insulin Resistance; Lipids; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; Sterol Regulatory Element Binding Protein 2; Streptozocin | 2020 |
Curcumin as a permeability enhancer enhanced the antihyperlipidemic activity of dietary green tea extract.
Topics: Animals; Antioxidants; Biological Availability; Catechin; Curcumin; Drug Evaluation, Preclinical; Drug Synergism; Female; Hyperlipidemias; Male; Permeability; Phytotherapy; Rats, Sprague-Dawley; Tea | 2019 |
Decaffeinated green tea extract rich in epigallocatechin-3-gallate improves insulin resistance and metabolic profiles in normolipidic diet--but not high-fat diet-fed mice.
Topics: Absorption, Physicochemical; Adipose Tissue, White; Adiposity; Animals; Anti-Obesity Agents; Biomarkers; Brazil; Camellia sinensis; Catechin; Diet, High-Fat; Dietary Supplements; Food Handling; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Male; Mice; Obesity; Plant Extracts; Plant Leaves; Random Allocation; Weight Gain | 2015 |